Difference between revisions of "Fibroblast growth factor receptors"
Jump to navigation
Jump to search
(create) |
|||
| Line 6: | Line 6: | ||
{{Reflist|1}} | {{Reflist|1}} | ||
[[Category:Molecular | [[Category:Molecular pathology]] | ||
Revision as of 16:18, 8 March 2024
Fibroblast growth factor receptor, abbreviated FGFR, a molecule that transmit growth signals for fibroblasts.
An anti-FGFR therapy exists (erdafitinib).[1][2]
References
- ↑ "Sustained response on sequential anti-FGFR therapy in metastatic gall bladder cancer: a case report and literature review". J Cancer Res Clin Oncol 149 (8): 4915–4923. July 2023. doi:10.1007/s00432-022-04428-w. PMID 36307559.
- ↑ "Fibroblast growth factor receptor (FGFR) gene: pathogenesis and treatment implications in urothelial carcinoma of the bladder". J Clin Pathol 74 (8): 491–495. August 2021. doi:10.1136/jclinpath-2020-207115. PMID 33731335.